| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-05 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-05 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-05 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-05 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.19 | 3e-05 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.26 | 4e-05 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.17 | 5e-05 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.21 | 5e-05 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-05 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-05 |